Similar articles for PMID: 17125407

Year	Number of Results
1957	1
1958	1
1984	1
1990	1
1991	1
1992	3
1994	1
1995	2
1996	4
1997	4
1998	4
1999	6
2000	6
2001	3
2002	4
2003	6
2004	2
2005	1
2006	5
2007	2
2008	8
2009	4
2010	3
2011	4
2012	3
2013	4
2014	3
2015	7
2016	11
2017	3
2019	1
2021	2
2022	1
2024	0

1

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Martignoni M, Groothuis GM, de Kanter R. Martignoni M, et al. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94. doi: 10.1517/17425255.2.6.875. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125407 Review.

2

Human hepatic cell cultures: in vitro and in vivo drug metabolism.

Gómez-Lechón MJ, Donato T, Ponsoda X, Castell JV. Gómez-Lechón MJ, et al. Altern Lab Anim. 2003 May-Jun;31(3):257-65. doi: 10.1177/026119290303100307. Altern Lab Anim. 2003. PMID: 15612868

3

Cytochrome P450-mediated metabolism in the human gut wall.

Thelen K, Dressman JB. Thelen K, et al. J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002. J Pharm Pharmacol. 2009. PMID: 19405992 Review.

4

Cytochromes P450 and experimental models of drug metabolism.

Zuber R, Anzenbacherová E, Anzenbacher P. Zuber R, et al. J Cell Mol Med. 2002 Apr-Jun;6(2):189-98. doi: 10.1111/j.1582-4934.2002.tb00186.x. J Cell Mol Med. 2002. PMID: 12169204 Free PMC article. Review.

5

Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.

Strolin Benedetti M, Whomsley R, Baltes E. Strolin Benedetti M, et al. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):895-921. doi: 10.1517/17425255.2.6.895. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125408 Review.

6

Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Singh SS. Singh SS. Curr Drug Metab. 2006 Feb;7(2):165-82. doi: 10.2174/138920006775541552. Curr Drug Metab. 2006. PMID: 16472106 Review.

7

Cytochrome P450 Enzymes and Drug Metabolism in Humans.

Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, Huai C, Shen L, Zhang N, He L, Qin S. Zhao M, et al. Int J Mol Sci. 2021 Nov 26;22(23):12808. doi: 10.3390/ijms222312808. Int J Mol Sci. 2021. PMID: 34884615 Free PMC article. Review.

8

Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.

Mei Q, Tang C, Assang C, Lin Y, Slaughter D, Rodrigues AD, Baillie TA, Rushmore TH, Shou M. Mei Q, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):749-59. J Pharmacol Exp Ther. 1999. PMID: 10525096

9

Comparison of minipig, dog, monkey and human drug metabolism and disposition.

Dalgaard L. Dalgaard L. J Pharmacol Toxicol Methods. 2015 Jul-Aug;74:80-92. doi: 10.1016/j.vascn.2014.12.005. Epub 2014 Dec 27. J Pharmacol Toxicol Methods. 2015. PMID: 25545337 Review.

10

Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.

Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA. Kalgutkar AS, et al. Biopharm Drug Dispos. 2006 Nov;27(8):371-86. doi: 10.1002/bdd.520. Biopharm Drug Dispos. 2006. PMID: 16944451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year